Want to see SENS full AI Analyst Report?
SENS Stock Chart & Stats
$9.34
$0.15(3.09%)
At close: 4:00 PM EDT
$9.34
$0.15(3.09%)
Day’s Range― - ―
52-Week Range$4.79 - $10.64
Previous Close$5
Volume283.30K
Average Volume (3M)670.00K
Market Cap
$434.10M
Enterprise Value$248.39M
Total Cash (Recent Filing)$142.66M
Total Debt (Recent Filing)$61.84M
Price to Earnings (P/E)―
Beta1.56
Next Earnings
Nov 09, 2026EPS Estimate
-0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.27
Shares Outstanding52,874,054
10 Day Avg. Volume616,528
30 Day Avg. Volume670,005
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)3.77
Price to Sales (P/S)6.53
P/FCF Ratio-3.82
Enterprise Value/Market Cap0.57
Enterprise Value/Revenue5.12
Enterprise Value/Gross Profit9.33
Enterprise Value/Ebitda-2.43
Forecast
1Y Price Target
$12.00Price Target Upside28.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)-2.28
Revenue Forecast (FY)$64.24M
Bulls Say, Bears Say
Bulls Say
Revenue And Gross-margin ImprovementImproving revenue and gross margin indicate stronger commercial traction and better economics for the Eversense platform. If sustained, this combination can increase contribution from each sale, support investment in commercialization, and create a clearer path toward operating leverage over the next several quarters.
Expanded European Commercial ControlGreater direct control of European commercial operations could improve execution, customer access, and coordination across important markets. It may also allow Senseonics to capture more of the platform’s commercial value and strengthen its operational position beyond reliance on external distribution arrangements.
Currently Positive Equity And Moderate LeveragePositive equity and moderate reported leverage provide a more stable starting point than the company’s earlier balance-sheet periods. This financial position may offer greater flexibility to support commercialization and manage obligations while the business works toward reducing losses and cash consumption.
Bears Say
Large And Widening LossesVery large losses show that operating expenses still materially exceed the revenue base, despite improving sales and gross margin. Continued losses weaken retained capital and make sustainable profitability dependent on substantial future growth, cost discipline, or additional financing to fund the business.
Severe And Worsening Cash BurnThe acceleration in operating cash burn is a durable funding weakness because the company is not yet generating cash internally to support operations. Persistent negative free cash flow can restrict investment choices, increase dependence on external capital, and amplify financing risk if losses continue.
History Of Balance-sheet InstabilityPrior periods of negative equity indicate that Senseonics has faced meaningful balance-sheet pressure and has depended on capital support while developing its business. Even with positive current equity, this history raises the risk that continued losses could again weaken capitalization and constrain strategic flexibility.
Senseonics Holdings News
SENS FAQ
What was Senseonics Holdings Inc’s price range in the past 12 months?
Senseonics Holdings Inc lowest stock price was $4.79 and its highest was $10.64 in the past 12 months.
What is Senseonics Holdings Inc’s market cap?
Senseonics Holdings Inc’s market cap is $434.10M.
When is Senseonics Holdings Inc’s upcoming earnings report date?
Senseonics Holdings Inc’s upcoming earnings report date is Nov 09, 2026 which is in 19 days.
How were Senseonics Holdings Inc’s earnings last quarter?
Senseonics Holdings Inc released its earnings results on Aug 06, 2026. The company reported -$0.63 earnings per share for the quarter, missing the consensus estimate of -$0.613 by -$0.017.
Is Senseonics Holdings Inc overvalued?
According to Wall Street analysts Senseonics Holdings Inc’s price is currently Undervalued.
Does Senseonics Holdings Inc pay dividends?
Senseonics Holdings Inc does not currently pay dividends.
What is Senseonics Holdings Inc’s EPS estimate?
Senseonics Holdings Inc’s EPS estimate is -0.52.
How many shares outstanding does Senseonics Holdings Inc have?
Senseonics Holdings Inc has 52,874,054 shares outstanding.
What happened to Senseonics Holdings Inc’s price movement after its last earnings report?
Senseonics Holdings Inc reported an EPS of -$0.63 in its last earnings report, missing expectations of -$0.613. Following the earnings report the stock price went up 36.311%.
Which hedge fund is a major shareholder of Senseonics Holdings Inc?
Currently, no hedge funds are holding shares in SENS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Senseonics Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (28.48% Upside)
$12.00 (28.48% Upside)
Blogger Sentiment
Bullish
SENS Sentiment 69%
Sector Average 67%
Sector Average 67%
Insider Transactions
Bought Shares
Worth $125.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.8%
Last 30 Days ▼ 1.7%
Last 30 Days ▼ 1.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.06%
12-Months-Change
Fundamentals
Return on Equity
-165.83%
Trailing 12-Months
Asset Growth
17.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Senseonics Holdings Inc
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
SENS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted strong commercial momentum and validating financial results: Q1 revenue of $11.7M (up 85% YoY), a 58% gross margin, rapid DTC growth (~100% YoY) and successful U.S. commercial integration. Management raised 2026 revenue guidance to $60M–$64M (70%–82% growth) and advanced pipeline milestones (Gemini and Freedom) while adding substantial growth capital ($92M equity + expanded $140M credit facility with a $20M draw). Offsetting these positives are materially higher operating expenses and an expanded net loss driven by in‑house commercialization, significant planned cash burn ($110M–$120M for 2026), increased debt, and remaining execution risk in the European transition and competitive landscape. On balance, the highlights from stronger-than-expected top-line performance, margin expansion and financing to fund growth outweigh the near-term cost and cash challenges, but execution through the rest of 2026 will be key.View all SENS earnings summariesSENS Stock 12 Month Forecast
Average Price Target
$12.00
▲(28.48% Upside)
Technical Analysis
Ownership Overview
5.73% Insiders
4.21% Mutual Funds
0.03% Other Institutional Investors
80.95% Public Companies and
Individual Investors